HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Surgical treatment of aneurysm of the left ventricle. Prognostic considerations].

Abstract
174 cardiac aneurysms were resected between 1970 and 1977. In 49 patients the remaining contractile segment was revascularised at the same time. The hospital mortality was 10.3%, the late mortality was 14%. The uncorrected cumulative survival rate calculated by the actuarial method was 90% at 3 years (84--96), and 80% at 5 years (74--85). Results were excellent or good in two thirds of the survivors; 44% were free of angina pectoris, 40% were improved, 73% had no disturbances of cardiac rhythm, and in 15% they were improved. Comparison of the pre- and post-operative ejection fraction showed that the indication for surgery of a cardiac aneurysm exists when more than 20% of the musculature of the left ventricle is affected, when the total ejection fraction is larger than 10% when one vessel is affected, and more than 30% when more than one vessel is affected. Contraindications are diffuse coronary heart disease, when ejection fraction of the contractile segment is less than 30%, reduction in contractility of the ventricular septum, and the generally applicable surgical contraindications.
AuthorsJ Weniger, J von der Emde, K Bachmann
JournalMinerva chirurgica (Minerva Chir) Vol. 35 Issue 7 Pg. 463-71 (Apr 15 1980) ISSN: 0026-4733 [Print] ITALY
Vernacular TitleTrattamento chirurgico dell'aneurisma del ventricolo sinistro. Considerazioni prognostiche.
PMID6990295 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Adult
  • Aged
  • Female
  • Heart Aneurysm (diagnosis, mortality, surgery)
  • Heart Ventricles
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: